ERBB3 and colorectal carcinoma: HER3 was also shown to be upregulated in CRC cells in response to factors secreted from liver endothelial cells (ECs), and blocking HER3 using a humanized anti-HER3 mAb seribantumab inhibited EC-induced CRC survival [39].